This article contains links to products or services from one or more of our advertisers or partners. We may receive a commission when you click or make a purchase using our site. Learn more about how we make money.

How to buy Allakos stock | $100.03

Own Allakos stock in just a few minutes.


Fact checked

Allakos Inc is a biotechnology business based in the US. Allakos shares (ALLK) are listed on the NASDAQ and all prices are listed in US Dollars. Allakos employs 103 staff and has a market cap (total outstanding shares value) of USD$4 billion.

How to buy shares in Allakos

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Allakos. Find the stock by name or ticker symbol: ALLK. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Allakos reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$100.03, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Allakos, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Allakos. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Allakos share price

Use our graph to track the performance of ALLK stocks over time.

Allakos shares at a glance

Information last updated 2020-10-19.
Latest market close USD$100.03
52-week range USD$41.605 - USD$139.99
50-day moving average USD$82.1506
200-day moving average USD$74.8723
Wall St. target price USD$82.8
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-1.61

Buy Allakos shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Stocks, Mutual funds, ETFs, Forex
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
$0 for US stocks
Stocks, Options, ETFs
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Allakos stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Allakos price performance over time

Historical closes compared with the close of $100.03 from 2020-11-16

1 week (2020-11-25) -3.57%
1 month (2020-11-06) 0.77%
3 months (2020-09-04) 19.48%
6 months (2020-06-05) 49.72%
1 year (2019-12-05) -18.71%
2 years (2018-12-04) 69.06%
3 years (2017-12-02) N/A
5 years (2015-12-02) N/A

Allakos financials

Gross profit TTM USD$0
Return on assets TTM -23.42%
Return on equity TTM -37.87%
Profit margin 0%
Book value $9.139
Market capitalisation USD$4 billion

TTM: trailing 12 months

Shorting Allakos shares

There are currently 6.4 million Allakos shares held short by investors – that's known as Allakos's "short interest". This figure is 3.2% down from 6.6 million last month.

There are a few different ways that this level of interest in shorting Allakos shares can be evaluated.

Allakos's "short interest ratio" (SIR)

Allakos's "short interest ratio" (SIR) is the quantity of Allakos shares currently shorted divided by the average quantity of Allakos shares traded daily (recently around 173897.09906951). Allakos's SIR currently stands at 36.54. In other words for every 100,000 Allakos shares traded daily on the market, roughly 36540 shares are currently held short.

However Allakos's short interest can also be evaluated against the total number of Allakos shares, or, against the total number of tradable Allakos shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Allakos's short interest could be expressed as 0.13% of the outstanding shares (for every 100,000 Allakos shares in existence, roughly 130 shares are currently held short) or 0.3466% of the tradable shares (for every 100,000 tradable Allakos shares, roughly 347 shares are currently held short).

A SIR above 20% would generally be considered very high, pointing to a pessimistic outlook for the share price, with a discouraging number of investors currently willing to bet against Allakos.

Find out more about how you can short Allakos stock.

Allakos share dividends

We're not expecting Allakos to pay a dividend over the next 12 months.

Allakos share price volatility

Over the last 12 months, Allakos's shares have ranged in value from as little as $41.605 up to $139.99. A popular way to gauge a stock's volatility is its "beta".

ALLK.US volatility(beta: 1.06)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Allakos's is 1.0551. This would suggest that Allakos's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Allakos overview

Allakos Inc. operates as a clinical stage biopharmaceutical company. The company is developing antolimab (AK002) for the treatment of eosinophilic gastritis and eosinophilic gastroenteritis, chronic urticaria, indolent systemic mastocytosis, and severe allergic conjunctivitis. Allakos Inc. was founded in 2012 and is headquartered in Redwood City, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site